Navigation Links
Boryung and Stendhal Expand Cardiovascular Partnership in Latin America
Date:8/26/2013

Mexico City (PRWEB) August 26, 2013

Boryung Pharmaceutical Co. and Stendhal have expanded their cardiovascular partnership with a license and distribution agreement for Boryung’s Arakor Plus, an ARB combined with HTCZ for the treatment of hypertension. Stendhal will launch the product under the brand name Diarakor in 13 Latin American countries.

This agreement expands Stendhal’s cardiovascular portfolio with four additional products based on Boryung’s novel ARB Fimasartan. Stendhal will invest over $40 million in the commercialization of the Fimasartan family of products from Boryung.

Tae-hong Choi, Boryung Pharmaceutical CEO said, "We are interested in Stendhal because it is a company that shares values and a corporate culture of innovation with Boryung. This is an agreement that goes beyond economic interest since it supports a segment of the population with a major illness and whose current therapies have not resulted in a completely effective treatment."

According to Dr. Gerardo Sanchez Mejorada, Medical Director of Stendhal Mexico, "This agreement allows the companies to move closer for the benefit of the population by attacking a problem like hypertension that has been well known as a silent killer and that affects a large proportion of the population".

Boryung and Stendhal share a long-term vision focused on launching innovative cardiovascular products for the benefit of patients in Latin America. With this second license and distribution agreement between the partners, Stendhal’s Cardiovascular franchise is well-positioned to become a market leader in Latin America.

About Stendhal

Stendhal is a pharmaceutical company specialized in innovative medicine and high specialty products that offer solutions to diseases threatening human life. The company is specialized in fighting infectious diseases such as HIV/AIDS, hospital acquired infections, conditions affecting central nervous system such as Multiple Sclerosis, and Cardio Metabolic conditions like hypertension. For more information on Stendhal, please visit: http://www.stendhalpharma.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11054147.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS enlists Archimedes Inc. to expand governments use of health care modeling
2. Data release from the Allen Institute for Brain Science expands online atlas offerings
3. Financial Press: Bralorne Gold Mines Strikes Expands on its Ultra-High Grade Gold System in Canada
4. Mahvrick Expands to Brazil, Russia, India, China to Support Existing Client Customer Growth
5. Test-Med Joins Forces with Mollen to Expand its Service Offerings to its Customers
6. Expanding Access to Medicaid Would Save Lives: Study
7. Expanding Medicaid to low-income adults leads to improved health, fewer deaths
8. Boston University researchers expand synthetic biologys toolkit
9. University of Pennsylvania and Novartis form alliance to expand use of personalized T cell cancer therapy
10. Expanding database enables discoveries in emerging field of metabolomics
11. U.S. Expands SIDS Prevention Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... ... , ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon ... America, declared on her radio program in November 2016 the need to educate people ... attack leaders in corporate America, they are trying to take advantage of successful algorithms ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Facial plastic ... this holiday season by donating a portion of proceeds to two local organizations: North ... Chicago Animal Control & Friends is a team of authorized and trained volunteers ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas ... "scam operations" carried out by unethical locksmith companies and is urging Search Engines ... halt. According to Texas Premier Locksmith, these fraudulent locksmith services take advantage of ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... Dec. 6, 2016   Sienna Biopharmaceuticals, ... dermatology and aesthetics company, today announced it ... specialty pharmaceutical company focused on developing first-in-class ... including psoriasis, atopic dermatitis and pruritus (itch). ... will make an undisclosed upfront payment in ...
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
Breaking Medicine Technology: